Combined nivolumab and ipilimumab versus ipilimumab alone...

  • Main
  • 2016 / 9
  • Combined nivolumab and ipilimumab versus ipilimumab alone...

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

Hodi, F Stephen, Chesney, Jason, Pavlick, Anna C, Robert, Caroline, Grossmann, Kenneth F, McDermott, David F, Linette, Gerald P, Meyer, Nicolas, Giguere, Jeffrey K, Agarwala, Sanjiv S, Shaheen, Montas
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(16)30366-7
Date:
September, 2016
File:
PDF, 510 KB
english, 2016
Conversion to is in progress
Conversion to is failed